Quarterly report · Q2
4272.TEDINET S100S30O
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥97.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥198.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥102.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥13.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥8.3bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥8.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥16.4bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥6.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥349.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥322.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥329.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥81.7bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥67.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥267.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥255.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥259.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥48.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥57.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥52.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥36.74 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.69 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.04 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.63 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.72 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.33 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥67.02 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 76.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥78m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥78m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥3.9bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥28.0bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥27.9bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥77m |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥39.5bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥39.5bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥98.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥97.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥78m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥8.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥82m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥82m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥3.7bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.7bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.6bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥7.2bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥30.0bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥30.0bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.2bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.2bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥102.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥102.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 573
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 35000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 11281000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 6092000000 | JPY |
| Profit loss | Prior1YTDDuration | 11324000000 | JPY |
| Profit loss | CurrentYTDDuration | 6128000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -1431000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 3191000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 7214000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 7407000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -173000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -35000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 0 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 1000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 5610000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 10564000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 16935000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 16692000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 16807000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 16563000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 127000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 128000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 16445000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 8840000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 6655000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 6710000000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | － | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 70000000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 272000000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 278000000 | JPY |
| Increase decrease in provision ope cf | Prior1YTDDuration | -114000000 | JPY |
| Increase decrease in provision ope cf | CurrentYTDDuration | 37000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -741000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -948000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 41000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 44000000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -1570000000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -1749000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | -6000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | -218000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1YTDDuration | -31000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | CurrentYTDDuration | -169000000 | JPY |
| Loss gain on disposal of property plant and equipment ope cf | Prior1YTDDuration | 211000000 | JPY |
| Loss gain on disposal of property plant and equipment ope cf | CurrentYTDDuration | 311000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -1250000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | 3000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | 511000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 2011000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -5670000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -8441000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |